NasdaqGS - Delayed Quote • USD
Mind Medicine (MindMed) Inc. (MNMD)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:46 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 6 |
Avg. Estimate | -0.42 | -0.37 | -1.55 | -1.47 |
Low Estimate | -0.56 | -0.49 | -2.07 | -1.67 |
High Estimate | -0.28 | -0.29 | -1.22 | -1.16 |
Year Ago EPS | -0.86 | -1.03 | -2.44 | -1.55 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 6 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.57 | -0.73 | -0.91 | -0.46 |
EPS Actual | -0.86 | -1.03 | -0.61 | -0.61 |
Difference | -0.29 | -0.3 | 0.3 | -0.15 |
Surprise % | -50.90% | -41.10% | 33.00% | -32.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.42 | -0.37 | -1.55 | -1.47 |
7 Days Ago | -0.42 | -0.37 | -1.55 | -1.47 |
30 Days Ago | -0.58 | -0.52 | -2.14 | -2.03 |
60 Days Ago | -0.57 | -0.51 | -2.1 | -1.99 |
90 Days Ago | -0.57 | -0.58 | -2.51 | -2.37 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 2 | 2 | 3 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | MNMD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 51.20% | -- | -- | 8.00% |
Next Qtr. | 64.10% | -- | -- | 12.40% |
Current Year | 36.50% | -- | -- | 5.60% |
Next Year | 5.20% | -- | -- | 13.00% |
Next 5 Years (per annum) | -- | -- | -- | 11.14% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
ATAI Atai Life Sciences N.V.
1.7100
-8.06%
CYBN Cybin Inc.
0.3500
-0.57%
RXRX Recursion Pharmaceuticals, Inc.
9.42
-0.95%
CYBN.NE Cybin Inc.
0.4700
0.00%
SEEL Seelos Therapeutics, Inc.
1.9001
-18.80%
BEAM Beam Therapeutics Inc.
24.62
+3.49%
VKTX Viking Therapeutics, Inc.
67.00
-2.98%
IBRX ImmunityBio, Inc.
7.65
-1.29%
CRSP CRISPR Therapeutics AG
56.22
+0.99%
IOVA Iovance Biotherapeutics, Inc.
10.24
-1.82%